2.03

1.93% -0.04

Clearmind Medicine Inc (CMND)

Überblick Nachrichten Preisverlauf Warum fällt CMND? Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$2.07

Offen:

$2.07

24-Stunden-Volumen:

95,877

Relative Volume:

0.04

Marktkapitalisierung:

$3.02M

Einnahmen:

Nettoeinkommen (Verlust:

$-6.64M

KGV:

-0.0113

EPS:

-179.3009

Netto-Cashflow:

$-5.60M

1W Leistung:

-13.98%

1M Leistung:

-36.56%

6M Leistung:

-91.36%

1J Leistung:

-99.48%

1-Tages-Spanne:

$2.03

$2.15

1-Wochen-Bereich:

$2.00

$2.35

52-Wochen-Spanne:

$2.00

$524.00

Clearmind Medicine Inc Stock (CMND) Company Profile

Firmenname

Clearmind Medicine Inc

Sektor

Healthcare (1096)

Branche

Biotechnology (616)

Telefon

Adresse

Mitarbeiter

Twitter

Nächster Verdiensttermin

2026-06-11

Neueste SEC-Einreichungen

CMND's Discussions on Twitter

Compare CMND vs VRTX, REGN, ARGX, ALNY, RVMD

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
CMND Clearmind Medicine Inc	2.03	3.02M	0	-6.64M	-5.60M	-179.30
VRTX Vertex Pharmaceuticals Inc	485.39	123.19B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	664.52	69.67B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	877.62	54.58B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	298.76	39.89B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	186.88	39.73B	742.00K	-1.37B	-1.07B	-7.0731

Clearmind Medicine Inc Aktie (CMND) Neueste Nachrichten

Jul 10, 2026

Clearmind Medicine Submits Formal Response To HHS RFI Highlighting MEAI-Based Candidate CMND-100 For Alcohol Use Disorder And Binge Behaviors - marketscreener.com

Jul 10, 2026

Clearmind submits addiction treatment proposal to U.S. HHS - Investing.com India

Jul 10, 2026

Clearmind submits MEAI addiction treatment prop... - Pluang

Jul 10, 2026

Clearmind Medicine Submits Response to HHS RFI Highlighting MEAI-Based CMND-100 for Alcohol Use Disorder - Quiver Quantitative

Jul 10, 2026

Jul 07, 2026

Clearmind Medicine (CMND) reports successful intranasal MEAI feasibility study - Stock Titan

Jul 07, 2026

Clearmind Medicine : Reports Successful Formulation Feasibility Study Supporting Potential New Additional Route of Administration for MEAI - marketscreener.com

Jul 07, 2026

CMND Stock Slides As Traders Gauge Cash Runway And Volatility - StocksToTrade

Jul 07, 2026

Clearmind Medicine Reports Successful Formulation Feasibility for Intranasal MEAI Development Program for Alcohol Use Disorder - Quiver Quantitative

Jul 07, 2026

Clearmind Reports Successful Formulation Feasibility Study Supporting Potential New Additional Route of Administration Development for MEAI - Yahoo Finance UK

Jul 07, 2026

Clearmind Medicine Company Profile & Introduction - Moomoo

Jul 07, 2026

Jul 02, 2026

symbol__ Stock Quote Price and Forecast - CNN

Jul 02, 2026

Jun 29, 2026

Clearmind Medicine receives U.S. patent for binge behavior treatment - Investing.com UK

Jun 29, 2026

Clearmind Medicine receives U.S. patent for binge behavior treatment By Investing.com - Investing.com Australia

Jun 29, 2026

Clearmind Medicine Advances Its Innovation with Newly Granted U.S. Patent, Enhancing Global Patent Strength - The Manila Times

Jun 29, 2026

Jun 27, 2026

Clearmind Medicine(CMND) Stock Options Chain | Quotes & News - Moomoo

Jun 27, 2026

Jun 26, 2026

Price to earnings forward of Clearmind Medicine Inc. – MUN:CWY0 - TradingView

Jun 26, 2026

Jun 25, 2026

Price to earnings forward of Clearmind Medicine Inc. – NASDAQ:CMND - TradingView

Jun 25, 2026

Enterprise value to revenue forward of Clearmind Medicine Inc. – NASDAQ:CMND - TradingView

Jun 25, 2026

Jun 24, 2026

Price to sales forward of Clearmind Medicine Inc. – NASDAQ:CMND - TradingView

Jun 24, 2026

Price to book forward of Clearmind Medicine Inc. – NASDAQ:CMND - TradingView

Jun 24, 2026

Jun 23, 2026

Clearmind Medicine Reaches Major Milestone, Completing Part a Treatment in FDA-Regulated Phase I/II Trial - marketscreener.com

Jun 23, 2026